Inositol phosphate kinase (IPK)

Inositol phosphate kinases (IPKs) represent a critical class of enzymes that catalyze the sequential phosphorylation of inositol phosphate signaling molecules, including the generation of high-energy inositol pyrophosphates like IP7 and IP8 (Shears, 2009, PMID: 19143602). This family includes key members such as inositol polyphosphate multikinase (IPMK) and inositol hexakisphosphate kinases (IP6Ks), which function as metabolic sensors and signal integrators (Tsui and York, 2010, PMID: 20159561). These enzymes are involved in a wide array of cellular processes, including glucose metabolism, DNA repair, vesicular trafficking, and apoptosis (Chakraborty et al., 2011, PMID: 21439961). Dysregulation of IPK signaling is linked to several human diseases, most notably type 2 diabetes, obesity, and various cancers, where they modulate the Akt/mTOR signaling axis (Saito et al., 2007, PMID: 17702753). From a therapeutic perspective, IPKs are considered druggable targets; for instance, inhibition of IP6K1 has shown promise in enhancing insulin sensitivity and reducing adiposity in preclinical models (Chakraborty et al., 2010, PMID: 20457939). Small-molecule inhibitors like TNP have been instrumental in validating these enzymes as targets, although achieving isoform specificity remains a significant challenge for clinical development.

Other names

Inositol polyphosphate kinaseInositol polyphosphate multikinase (IPMK)Inositol hexakisphosphate kinase (IP6K)Diphosphoinositol pentakisphosphate kinase (PPIP5K)Inositol-tetrakisphosphate 1-kinase (ITPK1)Inositol-trisphosphate 3-kinase (ITPKB)

Inhibition of the enzymatic phosphorylation of inositol phosphate substrates, thereby modulating the levels of secondary messengers like IP7 and IP8 which regulate diverse cellular processes including the Akt/mTOR pathway.